查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439220

除颤器 - 全球市场回顾、竞争格局、市场预测 (2030)

Defibrillator - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球除颤器市场规模预计到2023年将达到101.9亿美元，到2030年将达到122.4亿美元，2024-2030年预测期间复合年增长率为3.11%。对除颤器的需求主要与心臟病患病率的增加、先进技术的整合、政府和私营製造商增加投资以及有关心血管疾病和除颤器使用的意识计划的提高有关。

除颤器市场动态

心房颤动的特征是不规则、快速的心率，会增加老年人和患有高血压、肥胖和心臟病等慢性病的人中风、心臟衰竭和其他心臟相关併发症的风险。 。根据 NCBI 2022 上发表的一项研究，心房颤动是最常见的心律不整，2017 年全球有 3,046,000 人患有心房颤动。此外，根据世界卫生组织2022年的报告，85%的心血管疾病死亡是由于心臟病和中风所致。除颤器是一种透过向心臟发送电击来恢復正常心跳的装置，用于矫正或预防心律不整。因此，心臟相关疾病的日益普及可能会推动对去颤器的需求。

此外，几种具有简化植入技术、小型化以及减少或消除植入心臟的导线的新设备的推出也预计将增强除颤器市场。例如，Biotronik于2019年推出了新型ICD和Acticor设备系列心臟再同步治疗去颤器（CRT-D），混合ICD Acticor系统提供双腔诊断，无需心房导极。

然而，某些因素，例如缺乏对心臟骤停早期纠正措施的认识，预计将对除颤器市场的成长构成较小的障碍。

除颤器市场细分分析

在按产品类型划分的除颤器市场中，ICD（植入式除颤器）预计将占据最大的市场份额。ICD 有不同类型，包括单腔、双腔、皮下 ICD 和磁振造影 (MRI) 安全 ICD。例如，最近在除颤器领域开发的S-ICD与传统ICD和经静脉ICD相比具有许多优点。主要优点包括降低血管损伤和气胸的风险，并且无需导联线，使其成为患有先天性心臟病的儿童和无法静脉插入 ICD 的患者的理想选择。该装置比传统的静脉 ICD 具有更好的耐受性，从而增加了未来几年对 ICD 的需求。

此外，新产品的监管批准也有望快速成长市场。例如，最近在 2018 年，Abbott 获得 FDA 批准为Quadra Assura MP CRT-D和 Fortify Assura ICD 进行 MR 条件标籤。此外，该公司还获得了 FDA 对其 Ellipse ICD 的 MR 条件标籤的许可，Ellipse ICD 是该公司使用最广泛的 ICD 之一以及相关的高压导线。因此，最近的产品批准以及主要参与者增加基本医疗设备的製造预计将有助于除颤器市场的成长。

预计北美将主导整个除颤器市场。

在所有地区中，预计北美将在预测期内主导整个除颤器市场。这种主导地位是由于心血管疾病的盛行率不断上升、获得更好的医疗基础设施以及该地区主要市场参与者的存在。此外，涵盖植入设备的成本和程序的支持性报销计划进一步鼓励该地区的人们选择这些设备。

此外，在美国，心血管疾病的风险急剧增加。根据美国疾病管制与预防中心 (CDC) 统计，2020 年，心臟病是美国大多数男性和女性的第一大死因，每年约有 655,000 名美国人死于心臟病。该地区对心血管疾病的兴趣日益浓厚预计将推动市场发展。此外，Stryker、Abbott、Boston Scientific Corporation等主要製造商在该地区的存在推动了市场快速发展各种商业化和活动，包括ICD 和外部的联盟、产品发布、併购等。除颤器细分市场预计将成长并推动该地区的市场。

本报告提供了全球除颤器市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章除颤器市场报告简介

第二章除颤器市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章除颤器市场关键因素分析

  • 除颤器市场驱动因素
    • 心血管疾病盛行率上升
    • 除颤器领域的技术进步
    • 政府和私人製造商增加投资
    • 心血管疾病意识计划
  • 除颤器市场限制与挑战
    • 严格监管
    • 减少产品召回
  • 除颤器市场机会
    • 市场进入者增加对技术开发的投资
    • 新兴国家的增长机会

第 5 章 除颤器波特五力分析

第六章 除颤器市场布局

  • 按产品类型
    • 植入式除颤器
    • 体外去颤器
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 居家护理环境
    • 其他
  • 按地区
    • 北美除颤器市场规模（2021-2030）
    • 欧洲除颤器市场规模（2021-2030）
    • 亚太地区除颤器市场规模（2021-2030）
    • 其他地区除颤器市场规模（2021-2030）

第七章 除颤器公司及产品简介

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Stryker
  • Koninklijke Philips N.V
  • Zoll Medical Corporation
  • Microport Scientific Corporation
  • LivaNova PLC
  • Biotronik, Inc.
  • Nihon Kohden Corporation
  • SCHILLER AG
  • Bexen Cardio
  • Progetti S.r.l.
  • BPL Medical Technologies
  • Shenzhen Comen Medical Instruments Co., Ltd.

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第11章 免责声明

第 12 章. 关于 DelveInsight

Product Code: DIMDCL0005

Defibrillators Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centres, Homecare Settings, and Others), Geography is projected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of cardiac disorders and integration of advanced technology

Global Defibrillators Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030. The demand for defibrillators is primarily associated with the growing incidence of cardiac disorders, integration of advanced technology, increasing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders and the usage of defibrillators, among others.

Defibrillators Market Dynamics:

Atrial fibrillation which is characterized by an irregular and most often rapid heart rate can increase the risk of stroke, heart failure, and other heart-related complications in the old aged population and individuals suffering chronic conditions such as high blood pressure, obesity, and heart disorders. According to a study published in NCBI 2022, atrial fibrillation is the most frequent cardiac arrhythmia, and the worldwide incidence of atrial fibrillation in 2017 was registered to be 3.046 million. Moreover, as per the WHO 2022 report, 85% of all cardiovascular deaths are due to heart attacks and stroke. Defibrillators are devices used to restore a normal heartbeat by sending an electric shock to the heart and are used to correct or prevent arrhythmias. Therefore, the rising incidence of heart-associated disorders is likely to shoot the demand for defibrillators.

Further, the introduction of several new devices with simplified implantation technology, smaller size, and reducing or eliminating leads implanted in the heart is also anticipated to augment the market for defibrillators. For instance, in 2019, Biotronik launched the Acticor device family of new ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds), the hybrid ICD Acticor systems offer dual-chamber diagnostics without the need for an atrial lead.

However, certain factors such as lack of awareness regarding early corrective measures for sudden cardiac arrest are anticipated to pose a minor hurdle for the growth of the defibrillators market.

Defibrillators Market Segment Analysis:

Defibrillator Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Defibrillators product type segment, ICD (Implantable Cardioverter Defibrillator) is expected to hold the largest share in the market as there are different types of ICDs such as one-chambered, dual-chambered ICDs, subcutaneous ICDs, and magnetic resonance imaging (MRI)-safe ICDs available in the market. For instance, S-ICDs which are a recent development in the field of defibrillators have many advantages over traditional or transvenous ICDs. These mainly include lower risk of vascular injury or pneumothorax, the absence of leads is the main advantage making it a great alternative for children with congenital heart diseases or patients with no venous access who were unsuitable for transvenous ICD. Also, the device is more well tolerated than the traditional (transvenous) ICDs thereby raising the demand for ICDs in the coming years.

In addition, new product approvals in the market by regulatory bodies are also expected to surge the market. For instance, recently in the year 2018, Abbott received FDA approval for the MR-conditional labeling for the Quadra Assura MP CRT-D and Fortify Assura ICD. Moreover, the same company has received FDA clearance for MR-conditional labeling for one of the company's most widely used ICDs and associated high-voltage leads - the Ellipse ICD. Therefore, recent product approvals along with increased manufacturing of essential medical devices by key players are the factors expected to contribute to the defibrillators market growth.

North America is expected to dominate the overall Defibrillators Market:

Among all the regions, North America is expected to dominate the overall Defibrillator market during the forecast period. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region. Also, the supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.

Further, in the United States, the risk of being affected by cardiovascular disease is increasing dramatically. According to the CDC, in 2020, heart disease was the leading cause of death among most men and women in the United States and about 655,000 Americans died from heart disease each year in the region. The rising concern about cardiovascular disorders in the region is expected to boost the market. Furthermore, the presence of key manufacturers in the region such as Stryker, Abbott, and Boston Scientific Corporation, among others in the region will surge the market due to various commercialization activities including collaborations, product launches, merger acquisitions, and others in the field of both ICDs and External defibrillator is projected to fuel the market in the region. For instance, in 2019, Stryker launched LIFEPAK® CR2 Defibrillator with LIFELINK central(TM) AED Program Manager in the United States. Moreover, the rising installation of external defibrillators in public places apart from hospitals aiming to prevent sudden cardiac arrest is also a prominent factor contributing to the market growth. Hence, all these factors along with product launches are propelling the defibrillators market.

Europe and Asia-Pacific region have a future potential growth in the global defibrillators market. This is due to the rising burden of cardiovascular diseases in the European region countries and Asia countries also. The rising healthcare costs, improving healthcare infrastructure, and increase in disposable income in growing economies such as China, and India, among others are other factors that boost the market. In addition, countries such as Japan have a high penetration of defibrillators due to the presence of giant companies that are focused on expanding the market in other geographies is also likely to augment the global defibrillators market.

Defibrillators Market Key Players:

Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.

Recent Developmental Activities in Defibrillators Market:

In July 2020, Phillips received 510(k) clearances from the FDA for its professional defibrillator (Tempus LS- Manual), offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.

In June 2020, ZOLL® Medical Corporation, an Asahi Kasei Group Company received premarket approval (PMA) for its ZOLL AED 3® defibrillator with enhanced real CPR help, integrated child rescue, and wireless connectivity.

In February 2020, Abbott received CE Mark for the new Gallant(TM) implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices offer new opportunities for patient engagement and remote monitoring through new smartphone connectivity and connected applications. Additional benefits include a patient-preferred design, improved battery longevity, and MRI compatibility.

Key Takeaways from the Defibrillators Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Defibrillators market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Defibrillators Market.

Various opportunities available for the other competitor in the Defibrillators Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Defibrillators market growth in the coming future?

Target Audience who can be benefited from Defibrillators Market Report Study

Defibrillators providers

Research organizations and consulting companies

Defibrillators-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Defibrillators

Various End-users who want to know more about the Defibrillators Market and the latest technological developments in the Defibrillators market.

Frequently Asked Questions for Defibrillators Market:

What are Defibrillators?

Defibrillators are devices that give a high-energy electric shock to the heart of an individual who suffers a cardiac arrest. These can be implantable, external, and wearable based on their modality.

What is the market for Global Defibrillators?

Global Defibrillator Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030.

What are the drivers for Global Defibrillators Market?

The major factors responsible for driving the defibrillators market are the increasing prevalence of cardiac disorders, growing public-private investment in developing new and technologically advanced products, and rising awareness associated with defibrillators in cardiac-associated diseases in many countries.

What are the key players operating in Global Defibrillators Market?

Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.

What region has the highest share in the Defibrillators market?

North America is expected to dominate the overall Defibrillator market during the forecast period, 2024-2030 owing to the growing prevalence of cardiovascular diseases, access to improved healthcare infrastructure coupled with the presence of major market players in the region. Moreover, enhanced reimbursement programs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.

Table of Contents

1. Defibrillators Market Report Introduction

2. Defibrillators Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at a Glance
  • 2.3 Competitive Assessment

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Defibrillators Market Key Factors Analysis

  • 4.1 Defibrillators Market Drivers
    • 4.1.1 Rising Prevalence of Cardiovascular Diseases
    • 4.1.2 Technological Advancements in the Field of Defibrillators
    • 4.1.3 Increasing Investments by Government and private manufacturers
    • 4.1.4 Rising awareness programs regarding cardiovascular disorders
  • 4.2 Defibrillators Market Restraints and Challenges
    • 4.2.1 Stringent Regulations
    • 4.2.2 Fewer Product Recalls
  • 4.3 Defibrillators Market Opportunities
    • 4.3.1 Rise in Investment by market players for technological development
    • 4.3.2 Growth Opportunities in Emerging Nations

5. Defibrillators Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. Defibrillators Market layout

  • 6.1 By Product Type
    • 6.1.1 Implantable Cardioverter Defibrillators
      • 6.1.1.1 Single Chamber ICDs
      • 6.1.1.2 Dual Chamber ICDs
      • 6.1.1.3 Subcutaneous ICDs (S-ICD)
      • 6.1.1.4 CRT-D
    • 6.1.2 External Defibrillators
      • 6.1.2.1 Semi-Automated
      • 6.1.2.2 Automated
      • 6.1.2.3 Wearable
  • 6.2 By End-User
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Home Care Settings
    • 6.2.4 Others
  • 6.3 By Geography
    • 6.3.1 North America Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.1.1 United States Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.1.2 Canada Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.1.3 Mexico Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.2 Europe Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.1 France Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.2 Germany Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.3 United Kingdom Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.4 Italy Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.5 Spain Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.2.6 Rest of Europe Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.3 Asia-Pacific Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.1 China Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.2 Japan Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.3 India Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.4 Australia Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.5 South Korea Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.3.6 Rest of Asia-Pacific Defibrillators Market Size in USD Million (2021-2030)
    • 6.3.4 Rest of the World (RoW) Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.4.1 Middle East Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.4.2 Africa Defibrillators Market Size in USD Million (2021-2030)
      • 6.3.4.3 South America Defibrillators Market Size in USD Million (2021-2030)

7. Defibrillators Company and Product Profiles

  • 7.1 Abbott
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2 Medtronic
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3 Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4 Stryker
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5 Koninklijke Philips N.V
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6 Zoll Medical Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7 Microport Scientific Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8 LivaNova PLC
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9 Biotronik, Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10 Nihon Kohden Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11 SCHILLER AG
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12 Bexen Cardio
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13 Progetti S.r.l.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14 BPL Medical Technologies
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15 Shenzhen Comen Medical Instruments Co., Ltd.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Defibrillators Market in Global (2021-2030)
  • Table 3: Defribillators Market in Global by Product Type (2021-2030)
  • Table 4: Defribillators Market in Global by End-User (2021-2030)
  • Table 5: Defribillators Market in Global by Geography (2021-2030)
  • Table 6: Defibrillators Market in North America (2021-2030)
  • Table 7: Defribillators Market in the US (2021-2030)
  • Table 8: Defribillators Market in Canada (2021-2030)
  • Table 9: Defribillators Market in Mexico (2021-2030)
  • Table 10: Defribillators Market in Europe (2021-2030)
  • Table 11: Defribillators Market in France (2021-2030)
  • Table 12: Defribillators Market in Germany (2021-2030)
  • Table 13: Defribillators Market in the United Kingdom (2021-2030)
  • Table 14: Defribillators Market in Italy (2021-2030)
  • Table 15: Defribillators Market in Spain (2021-2030)
  • Table 16: Defribillators Market in Rest of Europe (2021-2030)
  • Table 17: Defribillators Market in Asia-Pacific (2021-2030)
  • Table 18: Defribillators Market in China (2021-2030)
  • Table 19: Defribillators Market in Japan (2021-2030)
  • Table 20: Defribillators Market in India (2021-2030)
  • Table 21: Defribillators Market in Australia (2021-2030)
  • Table 22: Defribillators Market in South Korea (2021-2030)
  • Table 23: Defribillators Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Defribillators Market in the Rest of the World (2021-2030)
  • Table 25: Defribillators Market in the Middle East (2021-2030)
  • Table 26: Defribillators Market in Africa (2021-2030)
  • Table 27: Defribillators Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Defribillators Market in Global (2021-2030)
  • Figure 3: Defribillators Market in Global by Product Type (2021-2030)
  • Figure 4: Defribillators Market in Global by End-User (2021-2030)
  • Figure 5: Defribillators Market in Global by Geography (2021-2030)
  • Figure 6: Defribillators Market in North America (2021-2030)
  • Figure 7: Defribillators Market in the US (2021-2030)
  • Figure 8: Defribillators Market in Canada (2021-2030)
  • Figure 9: Defribillators Market in Mexico (2021-2030)
  • Figure 10: Defribillators Market in Europe (2021-2030)
  • Figure 11: Defribillators Market in France (2021-2030)
  • Figure 12: Defribillators Market in Germany (2021-2030)
  • Figure 13: Defribillators Market in the United Kingdom (2021-2030)
  • Figure 14: Defribillators Market in Italy (2021-2030)
  • Figure 15: Defribillators Market in Spain (2021-2030)
  • Figure 16: Defribillators Market in Rest of Europe (2021-2030)
  • Figure 17: Defribillators Market in Asia-Pacific (2021-2030)
  • Figure 18: Defribillators Market in China (2021-2030)
  • Figure 19: Defribillators Market in Japan (2021-2030)
  • Figure 20: Defribillators Market in India (2021-2030)
  • Figure 21: Defribillators Market in Australia (2021-2030)
  • Figure 22: Defribillators Market in South Korea (2021-2030)
  • Figure 23: Defribillators Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Defribillators Market in the Rest of the World (2021-2030)
  • Figure 25: Defribillators Market in the Middle East (2021-2030)
  • Figure 26: Defribillators Market in Africa (2021-2030)
  • Figure 27: Defribillators Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER's Five Force Analysis